Zobrazeno 1 - 10
of 2 436
pro vyhledávání: ''
Autor:
Amel Zerroukhi, Martha Duraes, Julien Baleine, Jean-François Schved, Isabelle Cau-Diaz, Tarik Kanouni, Elodie Boissier, Olivier Dautremay, Lionel Moulis, Alexandre Theron, Eric Jeziorski, Christine Biron-Andreani, Michel Rodière
Publikováno v:
Blood Advances
Key Points IPF has a typical clinical presentation with involvement of the lower limbs corresponding to vascular territories.The antithrombin level and platelet count at diagnosis seemed to be associated with severe complications in IPF.
Visual
Visual
Autor:
Andy Warren, Michael A. Pulsipher, Theodore W. Laetsch, Stephen J. Schuster, G. Doug Myers, Peter Borchmann, John E. Levine, Michael Boyer, Edmund K. Waller, Edward Waldron, Stephan A. Grupp, Bernd Potthoff, Karen Thudium Mueller, Andrea Chassot-Agostinho, Ulrich Jaeger, Stephen Ronan Foley, Constantine S. Tam, Rakesh Awasthi, Keith J. August, Shannon L. Maude, Fraser McBlane
Publikováno v:
Blood Advances. 5:4980-4991
Tisagenlecleucel is indicated for pediatric and young adult patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) and adult patients with r/r diffuse large B-cell lymphoma (DLBCL). The tisagenlecleucel chimeric antigen r
Autor:
Angela C. Weyand, Veronica H. Flood
Publikováno v:
Hematology/Oncology Clinics of North America. 35:1085-1101
Von Willebrand disease (VWD) is a common bleeding disorder, affecting male and female individuals equally, that often manifests in mucosal bleeding. VWD can be secondary to a quantitative (Type 1 and Type 3) or qualitative (Type 2) defects in Von Wil
Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure
Autor:
Adam Lane, Kasiani C. Myers, Stella M. Davies, Anthony Sabulski, Sonata Jodele, Alexandra Duell, Jack J. Bleesing, Ashley Teusink-Cross
Publikováno v:
Blood Advances
Key Points CXCL9, BAFF, and sC5b-9 are potential biomarkers and therapeutic targets for graft rejection after transplant.Fever monitoring is a widely available and informative predictor of graft rejection after transplant.
Visual Abstract
G
Visual Abstract
G
Autor:
Juliana Rodríguez-Carrillo, Juan Mauricio Pardo-Oviedo, Santiago Sambracos-Parrado, María Fernanda Leal, Nora Contreras Contreras Bravo, David Corredor-Orlandelli, Oscar Ortega-Recalde, Valentina Vega-Ramírez, Katherine Parra Abaunza, Santiago David Mendoza-Ayús, Josué Tovar-Tirado, Laura Peña, Dora Janeth Fonseca Mendoza, Juanita León-Torres, Santiago Mantilla-García
Publikováno v:
Vascular Health and Risk Management
David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 Juliana Rodríguez-Carrillo,1 Juanit
The prognostic significance of bone marrow histological evaluation in patients with multiple myeloma
Autor:
Michał Michalak, Mieczysław Komarnicki, Andrzej Szczepaniak, Anna Przybylowicz-Chalecka, Lidia Gil, Macie Kaźmierczak, Violetta Filas
Publikováno v:
Acta Haematologica Polonica. 52:493-503
Introduction: Recently, there has been enormous progress in the diagnosis and treatment of multiple myeloma (MM). Despite the importance of flow cytometry and cytogenetic, biomarkers are being sought to assess prognosis and response to treatment. The
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
Publikováno v:
Journal of Thrombosis and Thrombolysis
INTRODUCTION: Coronavirus 2 (CoV-2) infection or coronavirus disease 2019 (COVID-19) is frequently associated with microvascular thrombosis.The microthrombosis in COVID-19 is the result of the interplay between inflammation and endotheliopathy. Eleva
Autor:
Clarence W Chan, Chancey Christenson, Fatima Aldarweesh, Geoffrey D. Wool, Ajay Major, Kenneth S. Cohen, Timothy Carll
Publikováno v:
Journal of Clinical Apheresis. 37:117-121
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a newly described hematologic disorder, which presents as acute thrombocytopenia and thrombosis after administration of the ChAdOx1 nCov-19 (AstraZeneca) and Ad26.COV2.S (Johnson & Johnson)
Autor:
Yun Li, Lingzhi Yan, Depei Wu, Mengjia Hou, Danqing Kong, Ziqiang Yu, Jingjing Shang, Zhaoyue Wang, Chengcheng Fu, Jie Yin
Publikováno v:
Leukemia & Lymphoma. 63:491-494
Acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder caused by a reduced concentration and/or function of von Willebrand factor (VWF) with no prior or family history of congenital vo...
Autor:
Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, Salman Otoukesh, Stephen J. Forman, Richard E. Champlin, Julianne Chen, Auayporn Nademanee, Michiko Taniguchi, Kai Cao, Ketevan Gendzekhadze, Fleur M. Aung, Jun Zou, Monzr M. Al Malki
Publikováno v:
Blood Advances. 5:4031-4043
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments are needed for these patients, who often have no other donor options an